ストックスクリーナーアプリを入手
4.315
0.82%
0.035
プレマーケット:
4.20
-0.115
-2.67%
Briacell Therapeutics Corp (BCTX) 最新ニュース
BriaCell Therapeutics Corp. (TSX:BCT): Immunotherapy Pipeline Progress and Clinical Momentum Drive Renewed Investor Confidence - kalkine.ca
Stocks in play: Medicenna Therapeutics Corp. - Yahoo! Finance Canada
BriaCell Therapeutics Warrant (BCTXL) Retreats 11.3% as Traders Test Support Near $0.97Factor Rotation - siam.in
Q&A: Advancing cancer biotech therapies with a multipronged approach - digitaljournal.com
Why Did BriaCell Therapeutics (TSX:BCT) Surge 18.876% on 17 September 2026? - kalkine.ca
BriaCell (BCTXZ) Rallies +1.01% as Bulls Target $0.16 2026-09-17ETF Premium Discount - siam.in
BriaCell (BCTX) Jumps +5.06% — Is Institutional Money Flowing In? 2026-09-17Butterfly Setup - dars.gov.et
BriaCell phase 3 breast cancer study gets seventh DSMB approval By Investing.com - Investing.com Nigeria
BriaCell (BCTX) Phase 3 Trial Safety Endorsement Highlights Mark - GuruFocus
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study - Investing News Network
BriaCell phase 3 breast cancer study gets seventh DSMB approval - Investing.com
BriaCell Therapeutics Receives Seventh Consecutive Positive DSMB Recommendation for Phase 3 Metastatic Breast Cancer Study - kalkine.ca
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
(BCT) Market Dynamics and Trading Signals (BCT:CA) - Stock Traders Daily
Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
Equity in earnings of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Book value per share of BriaCell Therapeutics Corp – HAM:8BT - TradingView
BriaCell Therapeutics Corp. (TSX:BCT) Advances as Immunotherapy Pipeline Progress and Clinical Momentum Drive Investor Optimism - kalkine.ca
Net income before discontinued operations of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Free float of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Nature Medicine features a BriaCell trial among 11 shaping medicine in 2026 - Stock Titan
BriaCell Therapeutics (BCTX) Edges Higher as Shares Hold Above Key Support at $3.42Volatility Breakout Picks - dars.gov.et
(BCT) Strategic Equity Report (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp (BCTXW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BriaCell Therapeutics Corp (BCTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Briacell Therapeutics Corp (BCTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Briacell Therapeutics Corp (BCTX) Peer Comparison – Compare with Others - Value Research
Briacell Therapeutics Corp (BCTX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation - Investing News Network
BriaCell Therapeutics Stock Faces Renewed Pressure as Biotech Volatility Tests Investor Conviction - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Falls 4.24% as Clinical-Stage Risk and Volatility Pressure Sentiment - kalkine.ca
BriaCell Therapeutics Corp (BCTXW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BriaCell Therapeutics Corp (BCTXW) Peer Comparison – Compare with Others - Value Research
Briacell Therapeutics Corp (BCTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BriaCell Therapeutics Stock Falls Sharply: Can TSX:BCT Stabilize After Renewed Biotech Selling Pressure? - kalkine.ca
BriaCell Therapeutics Stock Falls 6.41%: Why TSX:BCT Is in Focus as Breast and Prostate Cancer Pipeline Advances - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Gains Momentum as Immunotherapy Pipeline Progress Supports Investor Optimism - kalkine.ca
BriaCell Therapeutics (TSX:BCT) Advances 6.6% on a Run of Pipeline Milestones - kalkine.ca
BriaCell in Focus: TSX: BCT Investors Watch Major Immunotherapy Milestones Ahead of Clinical Data - kalkine.ca
BriaCell Therapeutics Stock Slides 13.31%: Can Clinical Execution Overcome Renewed Biotech Pressure? - kalkine.ca
BriaCell stock choppy on melanoma vaccine milestone - Investing.com
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ - Yahoo Finance
BriaCell stock choppy on melanoma vaccine milestone By Investing.com - Investing.com Australia
BriaCell (BCTXZ) Session: Advances 2.54% to $0.10 in Latest Trading; Next Test: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingShort Term Trading Ideas - vinanet.vn
BriaCell (BCTXL) Stock: Trades in a Narrow Directional Range at $1.00 in Latest Trading; Chart Watch: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotFibonacci Fan - vinanet.vn
Why Did BriaCell Therapeutics (TSX:BCT) Surge 12.37% on 19 August 2026? - kalkine.ca
BriaCell (BCTX) Results Breakdown: Reported EPS Tops Expectations in the Current Update; After Earnings - vinanet.vn
BriaCell Therapeutics Stock Rises 3.19% as Phase 3 Breast Cancer Trial and Bria-IMT Progress Draw Investor Interest - kalkine.ca
BriaCell Therapeutics Stock: A Breast-Cancer Immunotherapy Nears Late-Stage Data - kalkine.ca
BCTX Q2 2026 Earnings: Narrower-Than-Expected Loss of -$2.58 Beats Estimates by 47.22%Revenue Recognition Risk - Vinanet
Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BCTXL Holds Steady at $0.85 as BriaCell Warrant Trades in Tight RangeVolume Nodes - Vinanet
BriaCell Therapeutics Corp (TSX:BCT) Shares Decline as Biotech Uncertainty, Funding Risks and Clinical Execution Concerns Pressure Sentiment - kalkine.ca
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXL - TradingView
BriaCell Therapeutics Corp. (BCTXZ) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Briacell Therapeutics Corp (BCTX) Stock News Today - TradingKey
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):